Factors of the third-line treatment induction in advanced gastric cancer based on eligibility for clinical trials

In clinical practice, patients with advanced gastric cancer are not always eligible for clinical trials of first-line treatment with lower induction rate of subsequent treatment, resulting in poor survival outcomes. We identified factors of induction of third-line chemotherapy based on eligibility of clinical trial of the first-line treatment.